BPP has been appointed by Sekisui Diagnostics to assist with the rationalisation of their existing facilities. The project will include:
- assisting with identification, negotiation and procurement of new premises
- financial management of the fit out of new buildings
- negotiation of dilapidations on vacated premises
Sekisui Diagnostics has an annual revenue of $175 million and over 500 employees worldwide and is part of the Sekisui Medical family. They remain focused on innovation with a mission to deliver differentiated products, instrument systems and services that support the improvement of patient care worldwide. Their product line includes clinical chemistry systems and reagents, coagulation systems and reagents, and infectious disease rapid tests, LINE immunoassays, ELISA kits and instrumentation.
In providing these services BPP will be assisted by strategic partners as required. The new facilities which comprise both laboratory and office facilities will enable Sekisui to achieve both operational and commercial business efficiencies. It is anticipated that the project will complete by 1st quarter 2016.